BioCentury | May 19, 2014
Financial News

Proteon completes venture financing

...Management; Deerfield Management; Pharmstandard International; TVM Capital; Prism VentureWorks; Skyline Ventures; Intersouth Partners; MPM Capital; Devon Park Bioventures...
BioCentury | May 17, 2014
Financial News

Proteon secures $45 million in D round

...participated, along with existing investors TVM Capital; Prism VentureWorks; Skyline Ventures; Intersouth Partners; MPM Capital; Devon Park Bioventures...
BioCentury | Mar 10, 2014
Financial News

ZS Pharma completes venture financing

...million Investors: Novo A/S ; RA Capital Management; Adage Capital Management; Sofinnova Ventures; Alta Partners; Devon Park Bioventures...
BioCentury | Mar 6, 2014
Financial News

ZS Pharma raised $55 million in D round

...Ventures; and an additional undisclosed new investor also participated, along with existing investors Alta Partners; Devon Park Bioventures...
BioCentury | Sep 30, 2013
Financial News

Inotek completes venture financing

...Mass. Business: Ophthalmic, Renal, Autoimmune Date completed: 9/27/13 Type: Venture financing Raised: $21 million Investors: Devon Park Bioventures...
BioCentury | Sep 28, 2013
Financial News

Inotek raises $28 million

...million in a venture debt financing. All existing investors participated in the venture round, including Devon Park Bioventures...
BioCentury | Sep 2, 2013
Financial News

MicuRx completes venture financing

...Business: Infectious Date completed: 8/22/13 Type: Venture financing Raised: $25 million Investors: BVCF; Morningside Group; Devon Park Bioventures WIR...
BioCentury | Aug 22, 2013
Financial News

MicuRx raises $25 million in B round

...equity firm that invests in the life sciences in China. Existing investors Morningside Group and Devon Park Bioventures...
BioCentury | May 27, 2013
Financial News

Cardeas Pharma completes venture financing

...completed: 5/22/13 Type: Venture financing Raised: $34 million Investors: H.I.G. Capital; Novo A/S; Avalon Ventures; Devon Park Bioventures...
BioCentury | May 24, 2013
Financial News

Cardeas raises $34M in series B

...series B round led by new investor H.I.G. BioVentures. Existing investors Novo A/S; Avalon Ventures; Devon Park Bioventures...
Items per page:
1 - 10 of 26
BioCentury | May 19, 2014
Financial News

Proteon completes venture financing

...Management; Deerfield Management; Pharmstandard International; TVM Capital; Prism VentureWorks; Skyline Ventures; Intersouth Partners; MPM Capital; Devon Park Bioventures...
BioCentury | May 17, 2014
Financial News

Proteon secures $45 million in D round

...participated, along with existing investors TVM Capital; Prism VentureWorks; Skyline Ventures; Intersouth Partners; MPM Capital; Devon Park Bioventures...
BioCentury | Mar 10, 2014
Financial News

ZS Pharma completes venture financing

...million Investors: Novo A/S ; RA Capital Management; Adage Capital Management; Sofinnova Ventures; Alta Partners; Devon Park Bioventures...
BioCentury | Mar 6, 2014
Financial News

ZS Pharma raised $55 million in D round

...Ventures; and an additional undisclosed new investor also participated, along with existing investors Alta Partners; Devon Park Bioventures...
BioCentury | Sep 30, 2013
Financial News

Inotek completes venture financing

...Mass. Business: Ophthalmic, Renal, Autoimmune Date completed: 9/27/13 Type: Venture financing Raised: $21 million Investors: Devon Park Bioventures...
BioCentury | Sep 28, 2013
Financial News

Inotek raises $28 million

...million in a venture debt financing. All existing investors participated in the venture round, including Devon Park Bioventures...
BioCentury | Sep 2, 2013
Financial News

MicuRx completes venture financing

...Business: Infectious Date completed: 8/22/13 Type: Venture financing Raised: $25 million Investors: BVCF; Morningside Group; Devon Park Bioventures WIR...
BioCentury | Aug 22, 2013
Financial News

MicuRx raises $25 million in B round

...equity firm that invests in the life sciences in China. Existing investors Morningside Group and Devon Park Bioventures...
BioCentury | May 27, 2013
Financial News

Cardeas Pharma completes venture financing

...completed: 5/22/13 Type: Venture financing Raised: $34 million Investors: H.I.G. Capital; Novo A/S; Avalon Ventures; Devon Park Bioventures...
BioCentury | May 24, 2013
Financial News

Cardeas raises $34M in series B

...series B round led by new investor H.I.G. BioVentures. Existing investors Novo A/S; Avalon Ventures; Devon Park Bioventures...
Items per page:
1 - 10 of 26